Scribd
Upload
131 views1 page

Glibenclamide (Glibenclamidum) : The International Pharmacopoeia - Sixth Edition, 2016

This document provides specifications for the active pharmaceutical ingredient Glibenclamide, including its chemical name, molecular formula, category as an antidiabetic agent, and requirements for identity, purity, and assay. Key requirements include: - Glibenclamide contains between 98.5-101% of its chemical formula C23H28ClN3O5S. - Identity can be confirmed through infrared spectroscopy, ultraviolet spectroscopy, or melting point tests. - Impurities including heavy metals and sulfated ash must be below specified limits. - Assay involves titration with sodium hydroxide and is used to quantify the amount of active ingredient present.

Uploaded by

Yuda Anzas Mara
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
131 views1 page

Glibenclamide (Glibenclamidum) : The International Pharmacopoeia - Sixth Edition, 2016

This document provides specifications for the active pharmaceutical ingredient Glibenclamide, including its chemical name, molecular formula, category as an antidiabetic agent, and requirements for identity, purity, and assay. Key requirements include: - Glibenclamide contains between 98.5-101% of its chemical formula C23H28ClN3O5S. - Identity can be confirmed through infrared spectroscopy, ultraviolet spectroscopy, or melting point tests. - Impurities including heavy metals and sulfated ash must be below specified limits. - Assay involves titration with sodium hydroxide and is used to quantify the amount of active ingredient present.

Uploaded by

Yuda Anzas Mara
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

The International Pharmacopoeia - Sixth Edition, 2016 Glibenclamide (Glibenclamidum)

Glibenclamide (Glibenclamidum)
Molecular formula. C23H28ClN3O5S

Relative molecular mass. 494.0

Graphic formula.

Chemical name. 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexylurea; 5-chloro-N-[2-[4-


[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide; 1-[4-[2-(5-chloro-2-methoxybenzamido)ethyl]-
phenylsulfonyl]-3-cyclohexylurea; CAS Reg. No. 10238-21-8.

Other name. Glyburide.

Description. A white or almost white, crystalline powder; odourless or almost odourless.

Solubility. Practically insoluble in water and ether R; slightly soluble in ethanol (~750 g/l) TS and methanol R.

Category. Antidiabetic agent.

Storage. Glibenclamide should be kept in a well-closed container.

Requirements

Definition. Glibenclamide contains not less than 98.5% and not more than 101.0% of C23H28ClN3O5S, calculated with reference
to the dried substance.

Identity tests

• Either test A alone or tests B and C may be applied.

A. Carry out the examination as described under 1.7 Spectrophotometry in the infrared region. The infrared
absorption spectrum is concordant with the spectrum obtained from glibenclamide RS or with the reference
spectrum of glibenclamide.

B. The absorption spectrum of a 0.10 mg/mL solution in hydrochloric acid/ methanol (0.01 mol/l) VS, when
observed between 230 nm and 350 nm, exhibits a maximum at about 300 nm and a less intense maximum at
about 275 nm; the absorbance of a 1-cm layer at 300 nm is about 0.63.

C. Melting temperature, about 172 °C.

Heavy metals. Use 1.0 g for the preparation of the test solution as described under 2.2.3 Limit test for heavy metals, Procedure 3;
not more than 20 μg/g.

Sulfated ash. Not more than 1.0 mg/g.

Loss on drying. Dry to constant weight at 105°C; it loses not more than 10 mg/g.

Related substances. Carry out the test as described under 1.14.1 Thin-layer chromatography, using silica gel R4 as the coating
substance and a mixture of 45 volumes of chloroform R, 45 volumes of cyclohexane R, 5 volumes of ethanol (~750 g/l) TS, and 5
volumes of glacial acetic acid R as the mobile phase. Apply separately to the plate 10 μl of each of 2 solutions in chloroform R
containing (A) 10 mg of the test substance per mL and (B) 0.05 mg of the test substance per mL. After removing the plate from
the chromatographic chamber, allow it to dry in air and examine the chromatogram in ultraviolet light (254 nm). Any spot obtained
with solution A, other than the principal spot, is not more intense than that obtained with solution B.

Assay. Dissolve about 0.5 g, accurately weighed, in 100 mL of hot neutralized ethanol TS, and titrate with carbonate-free sodium
hydroxide (0.1 mol/l) VS, using phenolphthalein/ethanol TS as indicator. Repeat the operation without the substance being
examined and make any necessary correction. Each mL of carbonate-free sodium hydroxide (0.1 mol/l) VS is equivalent to 49.40
mg of C23H28ClN3O5S.

Page 1 of 1

You might also like